Oncologie, an international peer-reviewed journal with a group of the global experts who are leaders in oncology in the editorial board, aims to publish high-quality original research articles, review papers, case reports, etc. with an active interest in vivo or in vitro study of cancer biology. Oncologie focuses studies relating pathology, diagnosis, and advanced treatment of cancer and research from all disciplines related to this field of interest. More specifically, we are targeting the entire fields of cancer biology, including but not limited to the discovery of any new factors related to cancer initiation, progression, and systemic treatment. Other critical biological insights are considerable for sure.

Oncologie is aimed to the publication of high quality original research articles, review papers, case report, etc. with an active interest in vivo or vitro study of cancer biology. Study relating to the pathology, diagnosis, and advanced treatment of all types of cancers, as well as research from any of the disciplines related to this field of interest.

The journal is owned by Tech Science Press. La Société Française de Chirurgie Oncologique (SFCO), France, l’Association Francophone pour les Soins Oncologiques de Support (AFSOS), France, la Fédération Française des Oncologues Médicaux (FFOM), France, and the Malaysian Association for Cancer Research (MACR), Malaysia are affiliated with the journal Oncologie.

Oncologie is an open access journal. It has French and English publications, currently publishes English-language articles mainly. The publication frequency is bimonthly.